Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group (Q50587547)

16 March 2018

title

Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group (English)

1 reference

16 March 2018

1 reference

1 reference

1 reference

1 reference

J E Ware

1

1 reference

16 March 2018

M S Bayliss

series ordinal

2

1 reference

16 March 2018

M Mannocchia

series ordinal

3

1 reference

16 March 2018

G L Davis

series ordinal

4

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

16 March 2018

published in

Hepatology

1 reference

16 March 2018

volume

30

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

550-555

1 reference

16 March 2018

Health assessment for chronic HCV infection: results of quality of life.

cites work

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Comparative measurement sensitivity of short and longer health status instruments.

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Methods for assessing condition-specific and generic functional status outcomes after total knee replacement

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Time-limit tests: estimating their reliability and degree of speeding

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey.

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Measuring the functional status and well-being of patients with migraine headache.

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002/HEP.510300203

7 January 2021

Identifiers

DOI

10.1002/HEP.510300203

1 reference

16 March 2018

1 reference

16 March 2018